PRESS RELEASE [Press release] BioPlus secured the site of the Seongbon Industrial Complex in Chungbuk for 16.5 billion won, and “expanded production facilities”
PRESS RELEASE [Press release] Ubiprotein and Bioplus are promoting joint development of next-generation improved obesity treatments
PRESS RELEASE [Press release] BioPlus, which has 6.6 trillion won in subscriptions, “Leaps as a bio company that encompasses treatment and beauty.”
PRESS RELEASE [Press release] Bioplus, application of biomaterials and creation of new growth engines for bio-industry
PRESS RELEASE [Press release] BioPlus is focusing on the world’s only hyaluronic acid platform technology.
PRESS RELEASE [Press release] BioPlus passed preliminary screening on KOSDAQ listing, Promotion of IPO and overseas expansion
PRESS RELEASE [NEWS] BIOPLUS moves to Munjeong-dong, Business Center, to strengthen sales network and marketing
PRESS RELEASE [News] BioPlus’ filler and anti-adhesion agent approved by the UK’s Medicines and Healthcare Product Regulation Agency (MHRA).
